The U.S. Food and Drug Administration (US FDA) has said patients using diabetes devices that rely on smartphones, sometimes fail to receive alerts critical for their health.
Users of smartphone compatible devices like continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing systems often configure their settings so that they receive timely updates about their health. The growing popularity of these devices is driven by the convenience and improved disease management they offer. These devices, such as continuous glucose monitors (CGMs) seamlessly sync with smartphone apps, allowing users to track glucose levels in real time, set alerts, and analyze trends. Enhanced connectivity enables data sharing with healthcare providers and caregivers, improving treatment decisions. Advancements in wearable technology, AI-driven insights, and user-friendly mobile apps make diabetes management more accessible. The increasing focus on digital health solutions and the demand for remote monitoring further contribute to their widespread adoption.
